“These data present CBD as a potential target to combat not only molecular deficits in AD but also cognitive impairment,” the study’s authors concluded.
The post Preclinical Data Finds “Compelling” Evidence That CBD Offers a “Comprehensive Treatment Approach” to Alzheimer’s Disease appeared first on NORML.